Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Aligos Therapeutics, Inc. - Common stock (ALGS)

6.4100
+0.3200 (5.25%)
NASDAQ· Last Trade: Sep 2nd, 2:38 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Discover the top movers in Wednesday's pre-market session.chartmill.com
Via Chartmill · September 2, 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday's pre-market session. The company's market cap stands at $7.0 million. Aligos Therapeutics (NASDAQ:ALGS) shares
Via Benzinga · September 2, 2026
Keep an eye on the top gainers and losers in Monday's session.chartmill.com
Via Chartmill · August 10, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · July 8, 2026
Aligos Therapeutics (NASDAQ:ALGS) Surges After Hours on Q1 Earnings Beatchartmill.com
Via Chartmill · May 7, 2026
Aligos Therapeutics Inc (NASDAQ:ALGS) Reports Q4 Revenue Miss, Highlights 2026 Clinical Catalystschartmill.com
Via Chartmill · March 5, 2026
Earnings Scheduled For November 6, 2025benzinga.com
Via Benzinga · November 6, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
Earnings Scheduled For May 6, 2025benzinga.com
Via Benzinga · May 6, 2025
Aligos Therapeutics's Earnings Outlookbenzinga.com
Via Benzinga · May 5, 2025
Monday's after hours session: top gainers and loserschartmill.com
Via Chartmill · July 6, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · August 27, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · May 12, 2025
Monday's session: top gainers and loserschartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 10, 2025
How Is The Market Feeling About Aligos Therapeutics?benzinga.com
Via Benzinga · January 14, 2025
Recap: Aligos Therapeutics Q4 Earningsbenzinga.com
Via Benzinga · March 12, 2024
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · March 10, 2025
Top movers in Monday's pre-market sessionchartmill.com
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 10, 2025
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?benzinga.com
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.
Via Benzinga · March 10, 2025
Earnings Scheduled For March 10, 2025benzinga.com
Via Benzinga · March 10, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 13, 2025
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Dealtalkmarkets.com
Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus royalties.
Via Talk Markets · July 27, 2024
ALGS Stock Earnings: Aligos Therapeutics Misses EPS for Q1 2024investorplace.com
ALGS stock results show that Aligos Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 7, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · March 15, 2024
Earnings Scheduled For March 12, 2024benzinga.com
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via Benzinga · March 12, 2024